HAVCR2 and subcutaneous panniculitis-like T-cell lymphoma: Not only does it increase the risk of developing HLH/HLH-like systemic illnesses in patients with SPTCL, but the high prevalence of HAVCR2 mutations in our pediatric SPTCL population suggests that it can also accelerate the development of the disease at a young age.